Final Written Decision | Feb 21, 2017 | PAPER | BOARD |
Record of Oral Hearing | Feb 17, 2017 | PAPER | BOARD |
Decision Denying Patent Owner¿¿¿s Request for Rehearing | Nov 10, 2016 | PAPER | BOARD |
Order - 37 C.F.R. 42.70 | Nov 4, 2016 | PAPER | BOARD |
Patent Owner's Request for Oral Argument | Oct 13, 2016 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Argument | Oct 13, 2016 | PAPER | PETITIONER |
Patent Owner's Updated Mandatory Notice | Oct 12, 2016 | PAPER | PATENT OWNER |
Patent Owner's Limited Power of Attorney | Oct 12, 2016 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Response | Sep 29, 2016 | PAPER | PETITIONER |
Deposition of David A. Johnson | Sep 29, 2016 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List | Sep 29, 2016 | PAPER | PETITIONER |
Orange Book List for Vimovo | Sep 29, 2016 | EXHIBIT | PETITIONER |
Deposition of Robert W. Makuch | Sep 29, 2016 | EXHIBIT | PETITIONER |
Petitioner's Updated Mandatory Notices | Sep 28, 2016 | PAPER | PETITIONER |
Notice of Stipulation to Revise Due Date 2 | Aug 31, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Robert W. Makuch, Ph.D. | Aug 31, 2016 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of David A. Johnson, M.D. | Aug 4, 2016 | PAPER | PETITIONER |
Patent Owner's Response to Petition | Jun 23, 2016 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List | Jun 23, 2016 | PAPER | PATENT OWNER |
Gabriel, et al., Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-Inflammatory Drugs (1991) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Cryer, et al., Efects of Nonsteroidal Anti-inflammatory Drugs etc. (1992) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Fries, et al., Nonsteroidal Anti-inflammatory Drug-Associated Gastropathy etc. (1991) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Sorensen, et al., Risk of Upper Gastrointestinal Bleeding Associated with Use of Low-Dose Aspirin (2000) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Tamura, et al., Prevalence and independent factors for gastroduodenal ulcers/erosions etc. (2010) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Derry et al., Risk of gastrointestinal haemorrhage with long term use of aspirin etc. (2000) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Rodriguez, et al., Association between aspirin and upper gastrointestinal complications etc. (2001) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Bellary, et al., Upper Gastrointestinal Lesions in Elderly Patients etc. (1991) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Weil, et al., Prophylactic aspirin and risk of peptic ulcer bleeding (1995) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Goldsteun, et al., Effects of Concomitant Aspirin (81 mg qd) On Incidence of Gastric etc. (2006) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Rahme et al., Gastrointestinal Effects of Rofecoxib and Celecoxib Versus etc. (2004) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Silverstein, et al., Gastrointestinal Toxicity with Celecoxib vs Nonsteroidal Anti-inflammatory Drugs etc. (2000) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Deposition of Leon Shargel | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Declaration of Robert W. Makuch Ph.D | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Declaration of David A. Johnson MD | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Lee, et al., Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury (1994) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Serrano, et al., Risk of upper gastrointestinal bleedng in patients etc. (2002) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Chan, Anti-platelet therapy and managing ulcer risk (2012) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Goldstein, et al., The impact of low-dose aspirin on endoscopic gastric etc. (2006) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Goldstein, et al., Clinical trial incidence of NSAID-associated endoscopic etc. (2010) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Sostres, et al., Gastrointestinal Lesions and Complications etc. (2012) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Wolfe, et al., Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs (1999) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Flower, The Development fo COX2 Inhibitors (2003) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Public Health Advisory - FDA Announces Important Changes and Additional Warnings etc. (April 7, 2005) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Whitlock, et al., Bleeding Risks with Aspirin Use for Primary Prevention in Adults (2016) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Bombardier, et al., Comparison of Upper Gastrointestinal Toxicity etc. (2000) | Jun 23, 2016 | EXHIBIT | PATENT OWNER |
Updated Mandatory Notices | May 11, 2016 | PAPER | PATENT OWNER |
Power of Attorney | May 11, 2016 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Leon Shargel, Ph.D., R.PH. | May 10, 2016 | PAPER | PATENT OWNER |
Notice of Joint Stipulation to Revise Due Dates 1 and 2 | Apr 6, 2016 | PAPER | PATENT OWNER |
Petitioners_Opposition_to_Patent_Owners_Request_for_Rehearing_of_the_Decision_to_Institute_Trial | Mar 24, 2016 | PAPER | PETITIONER |
Motion for Rehearing | Mar 4, 2016 | PAPER | PATENT OWNER |
Scheduling Order | Feb 23, 2016 | PAPER | BOARD |
Decision Institution of Inter Partes Review | Feb 22, 2016 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Jan 20, 2016 | PAPER | PETITIONER |
Preliminary Response | Nov 23, 2015 | PAPER | PATENT OWNER |
Bhatt | Nov 23, 2015 | EXHIBIT | PATENT OWNER |
Angiolillo 2013 | Nov 23, 2015 | EXHIBIT | PATENT OWNER |
Laine | Nov 23, 2015 | EXHIBIT | PATENT OWNER |
PREVACID 2001 | Nov 23, 2015 | EXHIBIT | PATENT OWNER |
Simon Decl. | Nov 23, 2015 | EXHIBIT | PATENT OWNER |
Goldstein 2009 | Nov 23, 2015 | EXHIBIT | PATENT OWNER |
Pozen Updated Mandatory Notices | Oct 20, 2015 | PAPER | PATENT OWNER |
Pozen Updated POA | Oct 20, 2015 | PAPER | PATENT OWNER |
Pozen's Updated Mandatory Notice | Oct 1, 2015 | PAPER | PATENT OWNER |
Pozen Power of Attorney | Oct 1, 2015 | PAPER | PATENT OWNER |
Power of Attorney | Sep 15, 2015 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Sep 15, 2015 | PAPER | PETITIONER |
Exhibit List | Sep 4, 2015 | PAPER | PATENT OWNER |
Ex. 2001 License Agreement | Sep 4, 2015 | EXHIBIT | PATENT OWNER |
Power of Attorney | Sep 2, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Power of Attorney | Sep 2, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Sep 2, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | Aug 24, 2015 | PAPER | BOARD |
Petition | Aug 12, 2015 | PAPER | PETITIONER |
Power of Attorney | Aug 12, 2015 | PAPER | PETITIONER |
Exhibit List | Aug 12, 2015 | PAPER | PETITIONER |
Ex. 1001 US8945621 (621 Patent) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1002 612 Application File History Pt. A | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1002 612 Application File History Pt. B | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1002 612 Application File History Pt. C | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1002 612 Application File History Pt. D | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1002 612 Application File History Pt. E | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1003 Declaration of Leon Shargel | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1004 US6926907 (Plachetka) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1005 Ulcer Prevention in Long-term Users (Graham) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1006 Ulcer Recurrence in High-Risk Patients (Goldstein) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1007 Horizon Pharma Announces Agreement | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1008 2014 Horizon Pharma plc Irish Statutory Accounts | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1009 Pharmaceutical Companies Buy Rivals Drugs | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1010 US4757060 (Lukacsko) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1011 The Mechanism of Action of Aspirin (Vane) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1012 GB1211134 (Syntex) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1013 Drug-Induced Peptic Ulcer Disease (Vella) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1014 Goodman and Gilmans | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1015 Upper Gastrointestinal (GI) pH (Dressman) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1016 Effect of Orally Administered Prostaglandin (Karim) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1017 Tagamet (ACS) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1018 Inhibition of Gastric (Wallmark) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1019 US4255431 (Junggren) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1020 Notice of Final Determination | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1021 Drug Discovery (Li) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1022 Prevention of the Gastrointestinal (Brown) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1023 US20020045184 (Chen) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1024 US5698225 (Gimet) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1025 Management of NSAID (Barrison) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1026 Prevention of NSAID (Rostom) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1027 Abolition by Omeprazole (Daneshmend) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1028 US6319519 (Woolfe) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1029 Remington | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1030 US6365184 (Depui) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1031 VIMOVO | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1032 Shargel Wal-Mart Receipts | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1033 US6224911 (Chowhan) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1034 WO0119346A1 (Copley Pharmaceutical) | Aug 12, 2015 | EXHIBIT | PETITIONER |
Ex. 1035 Pharmacology of Proton Pump Inhibitors (Shin) | Aug 12, 2015 | EXHIBIT | PETITIONER |